Olopatadine HCL 0.1% Ophthalmic Solution
SPE2D222R0117 · DEPT OF DEFENSE
A PHARMACEUTICAL PREPARATION MANUFACTURING solicitation, performed in Ontario, Canada. AwardCast estimates what this specific solicitation will close for, before you bid.
SPE2D222R0117
solicitation
325412
NAICS
6505
PSC
Not set aside
set-aside
Ontario, Canada
place
What's being bought
Modification SPE2D223D0007 P00004 to exercise Option Year 1 effective February 15, 2024 through February 14, 2025. Modification SPE2D223D0007 P00003 to incorporate Drug Supply Chain Security Act language into solicitation for subject contract. Modification SPE2D223D0007 P00002 to incorporate clause
Comparable recent awards in PHARMACEUTICAL PREPARATION MANUFACTURING
| Winner | Award value | Offers | Date |
|---|---|---|---|
| SR-SERVICES GMBH | $25K | 2 | 2024-09-30 |
| AMERICAN REGENT INC | $926 | n/a | 2024-09-30 |
| PFIZER INC | $2.2M | 4 | 2024-09-30 |
| ADVANCED ACCELERATOR APPLICATIONS USA INC | $1.9M | n/a | 2024-09-30 |
| FRESENIUS KABI USA, LLC | $5.4M | 4 | 2024-09-30 |
Explore the market
Comparable awards ran from $926 to $5.4M. Get AwardCast's forecast for THIS solicitation's closing price.
AwardCast forecasts what U.S. federal contracts close for, before you bid. Built on USASpending and SAM.gov. Not affiliated with the U.S. government. Technology by Chosing DEPT.